Barredo et al., 2020 - Google Patents
A short peptide fragment of the vascular endothelial growth factor as a novel ligand for bevacizumab purificationBarredo et al., 2020
- Document ID
- 9195919637168216436
- Author
- Barredo G
- Giudicessi S
- Ceron M
- Saavedra S
- Rodriguez S
- Risso L
- Erra-Balsells R
- Mahler G
- Albericio F
- Cascone O
- Camperi S
- Publication year
- Publication venue
- Protein Expression and Purification
External Links
Snippet
Bevacizumab is a vascular endothelial growth factor (VEGF)-directed monoclonal antibody (mAb) used for the treatment of several human cancers. Given that bevacizumab is administered intravenously, it must have extremely high purity, which is achieved by …
- 108010005144 Bevacizumab 0 title abstract description 87
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12331075B2 (en) | Optimized method for antibody capturing by mixed mode chromatography | |
| Menegatti et al. | Design of protease-resistant peptide ligands for the purification of antibodies from human plasma | |
| CA2791918C (en) | Selective enrichment of antibodies | |
| O’Connor et al. | Monoclonal antibody fragment removal mediated by mixed mode resins | |
| Barredo et al. | A short peptide fragment of the vascular endothelial growth factor as a novel ligand for bevacizumab purification | |
| US11332514B2 (en) | Cation and anion exchange chromatography method | |
| CA2857194A1 (en) | Igg2 disulfide isoform separation | |
| D'Agostino et al. | Affinity purification of IgG monoclonal antibodies using the D-PAM synthetic ligand: chromatographic comparison with protein A and thermodynamic investigation of the D-PAM/IgG interaction | |
| WO2012099949A2 (en) | Antibody purification via affinity chromatography | |
| JP2023505216A (en) | VEGF mini-traps and methods of their use | |
| Chu et al. | Development of peptide ligands for the purification of α-1 antitrypsin from cell culture fluids | |
| JP5635682B2 (en) | Hydrophobic interaction chromatography method | |
| Matos et al. | A purification platform for antibodies and derived fragments using a de novo designed affinity adsorbent | |
| CN106478797B (en) | Tumour antigen small peptide from SAGE1 | |
| US20250215050A1 (en) | Compositions and methods for purifying biological fluids | |
| JP6024101B2 (en) | Adsorbent for blood coagulation factor or cell adhesion factor and purification method | |
| CN110582510B (en) | Methods for purifying recombinant antibody fragments | |
| EP4414386A1 (en) | Method of chemical synthesis of single-chain antibody fragments and products thereby obtained | |
| Coughlin et al. | A simple enzyme–substrate localized conjugation method to generate immobilized, functional glutathione S-transferase fusion protein columns for affinity enrichment | |
| US20240174712A1 (en) | Compositions and methods for purifying alpha-1 antitrypsin using peptide ligands | |
| EP1621546B1 (en) | Peptide ligands specific to immonoglobulins | |
| WO2024077083A2 (en) | Compositions and methods for purifying antigen-binding antibody fragments using peptide ligands | |
| Yang | Fc-binding hexamer peptide ligands for immunoglobulin purification | |
| HK40052155A (en) | Optimized process for dimeric peptide-phospholipid conjugate | |
| CN113164613A (en) | Method for optimizing dimeric peptide-phospholipid conjugates |